Vilazodone and Certoparin: Interaction Details
- Vilazodone
- Viibryd
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Vilazodone and Certoparin interaction:
Certoparin
We don't have a drug information page for Certoparin yet. Have a question about Certoparin? Ask a pharmacist, free →
What Happens When You Take Vilazodone With Certoparin
What can happen when they are taken together (rated Major)
An increased risk of bleeding
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Vilazodone should be coadministered with or agents only with caution, since taking them together may raise the likelihood of bleeding.312 The mechanism may involve vilazodone's influence on release from . Patients should be told that using vilazodone together with antiplatelet drugs or anticoagulants carries a greater risk of bleeding.1
The Vilazodone and Certoparin Interaction, Explained
Vilazodone (Viibryd) is an antidepressant that affects . , the tiny cells that help your blood clot, use serotonin, so this type of medicine can make clotting a bit less effective. Certoparin is a (a low molecular weight heparin) that also lowers your ability to form clots. Taken together, you may be more likely to bleed or bruise more easily. This concern is mostly based on how the drugs work, not on proven cases.
Keep taking both as prescribed. Tell your pharmacist or doctor about any unusual bruising, nosebleeds, black stools, or blood in your urine. Your care team can watch you closely and manage this safely.
Mechanism: Vilazodone, an and 5-HT1A partial , inhibits reuptake, which depletes serotonin stores and impairs platelet aggregation. Certoparin, a low molecular weight heparin, potentiates antithrombin-mediated of factor Xa (and to a lesser extent IIa). The result is effects on hemostasis (PD interaction). No interaction is described.
- Direction: increased bleeding risk.
- Evidence: theoretical; onset unspecified; severity on file: major.
- Management: use with caution, inform the patient of the bleeding risk, and monitor for signs of bleeding (bruising, bleeding, hematuria, epistaxis). Consider hemoglobin and clinical monitoring as appropriate, and reassess if bleeding signs appear.
See the 3 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Vilazodone and Certoparin Interact
The likely mechanism
Release of by ; effects on hemostasis
How to Manage the Vilazodone and Certoparin Interaction
Your care team can usually continue both medicines while keeping a closer eye on you for bleeding.
- Keep taking both exactly as prescribed. Do not stop or change either one on your own.
- Your team may monitor you more closely, and your care plan may be individualized.
- Tell your pharmacist or prescriber right away about unusual bruising, nosebleeds, bleeding gums, black or bloody stools, or blood in your urine.
- Check with your pharmacist before adding any new medicines, especially pain relievers like aspirin or .
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Vilazodone or Certoparin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
3 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction
A retrospective study enrolled patients older than 50 years with a diagnosis of acute myocardial infarction (N=27,058). In this cohort, taking an together with any therapy raised the risk of bleeding significantly, by 1.42-fold, relative to aspirin alone. The combination of aspirin, clopidogrel, and an SSRI raised the risk significantly by 2.35-fold relative to aspirin alone, and by 1.57-fold relative to combined clopidogrel and aspirin therapy.2
-
Report 2 · Study title
Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis
A systematic review and meta-analysis of 22 observational studies found that use was associated with a significant 1.55-fold increase in the risk of upper bleeding (UGIB). When were used together with drugs, the risk of UGIB was increased 2.48-fold (3 studies).3
-
Report 3 · Study title
Prescribing information: VIIBRYD oral tablets, vilazodone HCl oral tablets
Case-control and cohort studies have linked the combined use of selective and norepinephrine reuptake (such as vilazodone) with agents to a higher risk of bleeding. Published observational data indicate that exposure, especially during the month before delivery, has been associated with an increase of less than 2-fold in the risk of postpartum . The reported bleeding events have included epistaxis, ecchymosis, hematoma, petechiae, and life-threatening hemorrhages.1
Vilazodone and Certoparin: Common Questions
How serious is the Vilazodone and Certoparin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Vilazodone and Certoparin interaction managed?
Your care team can usually continue both medicines while keeping a closer eye on you for bleeding. Keep taking both exactly as prescribed. Do not stop or change either one on your own. Your team may monitor you more closely, and your care plan may be individualized. Tell your pharmacist or prescriber right away about unusual bruising, nosebleeds, bleeding gums, black or bloody stools, or blood in… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Vilazodone and Certoparin Interaction
Ask in your own words about taking Vilazodone and Certoparin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (3)
- Product Information: VIIBRYD(R) oral tablets, vilazodone HCl oral tablets. Allergan USA Inc (per FDA), Madison, NJ, 2023. DailyMed
- Labos C, Dasgupta K, Nedjar H, et al: Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ 2011; 183(16):1835-1843. PubMed
- Jiang HY, Chen HZ, Hu XJ, et al: Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2015; 13(1):42-50. PubMed
Other Serious Interactions of Vilazodone and Certoparin
Also serious with Vilazodone
- Linezolid InjectionContraindicated
- Metoclopramide InjectionContraindicated
- Metoclopramide Nasal SprayContraindicated
- IsocarboxazidContraindicated
Also serious with Certoparin
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Vilazodone
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- LithiumMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Black PepperModerate
- + 172 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.